EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update

Florian Roßner iD, Bruno Valentin Sinn, David Horst

Cancers · 13.01.2023 · 15 (2) · 494

DOI: 10.3390/cancers15020494 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 13.01.2023. Verfasst von Florian Roßner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA) is a rare primary liver cancer that is composed of both hepatocellular and cholangiocellular differentiated cells. It is slightly more common in men and among Asian and Pacific islanders. Overall, risk factors are similar to classic risk factors of hepatocellular carcinoma (HCC). The classification has significantly evolved over time. The last WHO classification (2019) mainly emphasized diagnosis on morphological basis with routine stainings, discarded previously recognized classifications with carcinomas with stem cell features, introduced intermediate cell carcinoma as a specific subtype and considered cholangiolocarcinoma as a subtype of cholangiocellular carcinoma. Immunohistochemical markers may be applied for further specification but have limited value for diagnosis. Recent discoveries in molecular pathway regulation may pioneer new therapeutic approaches for this poor prognostic and challenging diagnosis.

Schlagwörter

Stichwörter der Autor:innen

cHCC-CCAcholangiocarcinomacombined hepatocellular and cholangiocellular carcinomahepatocellular carcinomahippo signalingmixed carcinomaprogenitor cellsstem cellswnt signaling

Autor:innen und Institutionen

  • Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

ORCID-Profile: Florian Roßner

Zitieren

APA

Roßner, F., Sinn, B. V., & Horst, D. (2023). Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update. Cancers, 15(2), 494. https://doi.org/10.3390/cancers15020494

Vancouver

Roßner F, Sinn BV, Horst D. Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update. Cancers. 2023;15(2):494. doi:10.3390/cancers15020494

BibTeX
@article{Roner2023,
  author = {Roßner, Florian and Sinn, Bruno Valentin and Horst, David},
  title = {Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {494},
  doi = {10.3390/cancers15020494}
}
Kostenlos starten →